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injection. The mean age of the patients was 57 years in the physiotherapy group and 58 years in the injection group. Eight sets of notes were excluded from the analysis, two from the physiotherapy group and six from the injection group. Such exclusions were because of patients moving (4), patients denying consent (2), death (1) and missing records (1).
Study design
The authors designed a pragmatic randomised controlled trial, and the patients were randomised and treated accordingly. However, after the 6-week assessment, GPs were permitted to prescribe other treatments if clinically indicated. The study was based at nine general practices in North Staffordshire. The patients were followed until 6 months post randomisation, at which point they were assessed by a blinded study nurse.
Analysis of effectiveness
The patients were analysed according to intention to treat. The primary outcome was shoulder disability at 6 months, measured using a shoulder disability questionnaire (Croft 1994, see ,Other Publications of Related Interest-below for bibliographic details). The authors did not report summary statistics for the two sample groups and did not discuss the presence or absence of confounding factors. These might have been discussed in the article by Hay et al (2003) .
Effectiveness results
The mean disability score at baseline was 10.85 (standard deviation, SD=4.4) for the physiotherapy group and 10.96 (SD=4.7) for the injection group.
The mean disability score at 6 months was 4.85 (SD=4.9) for the physiotherapy group and 6.40 (SD=6.2) for the injection group.
The global assessment of percentage change was also presented in the paper.
Clinical conclusions
The authors concluded that there were similar outcomes in the two patient groups.
Measure of benefits used in the economic analysis
The secondary outcomes were EQ5D (EuroQol Group Business Management), the participant's global assessment of change, pain severity, and the impairment of function and severity of 'main complaint' (Beurskens et al. 1995, see ,Other Publications of Related Interest-below for bibliographic details); these measures were the authors' summary measures of health benefit. The authors reported that the measures were designed to capture different dimensions of health-related quality of life. The authors did not state whether each of these measures was validated for the study population.
